In rats with induced periodontitis, treatment with nootkatone significantly reduced the levels of inflammatory markers, such as IL-1β, IL-6, and TNF-α within the gingival tissue, showcasing its potential to protect against the degradation of alveolar bone. This evidence concerns the gene IL1B and periodontitis.